Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.390 +0.050 (+0.79%)
Streaming Delayed Price Updated: 9:35 AM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
News headline image
After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding ↗
Shares of cell programming platform company Ginkgo Bioworks Holdings Inc (NYSE: DNA) are moving lower after hours on the heels of a wider-than-expected quarterly loss.&nbs 
Via Benzinga
News headline image
DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates ↗
DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates. 
Via InvestorPlace
News headline image
Ginkgo Bioworks Holdings: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Preview: Ginkgo Bioworks Holdings ↗
 
Via Benzinga
News headline image
Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around? ↗
Ginkgo is coming off a strong performance in 2022, but this year will no doubt be a more challenging one for the business. 
Via The Motley Fool
News headline image
7 Best Cathie Wood Stocks for Your May 2023 Buy List ↗
This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent. 
Via InvestorPlace
News headline image
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock ↗
Wood is betting that Ginkgo Bioworks' biofoundry can scale up enough to become profitable. 
Via The Motley Fool
News headline image
Earnings Scheduled For March 1, 2023 ↗
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million. 
Via Benzinga
News headline image
Ginkgo Bioworks Holdings's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Is It Too Early to Invest in Ginkgo Bioworks? ↗
Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line? 
Via The Motley Fool
News headline image
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries ↗
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
Via Talk Markets
News headline image
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Ginkgo Bioworks Holdings, Inc.. 
Via SBWire
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
The growth-focused money manager is making moves. 
Via The Motley Fool
News headline image
Cathie Wood Bets Big On Roblox With $19.5M Purchase — Also Loads Up On This Biotech Stock ↗
 
Via Benzinga
News headline image
5 Penny Stocks With Explosive 5X Potential ↗
Penny stocks are inherently risky, but investing in low-priced companies with wide "moats" can shift the odds in investors' favor. 
Via InvestorPlace
News headline image
3 Growth Stocks to Buy for 100% Returns ↗
These three growth stocks to buy could provide triple-digit percentage returns for investors in the near to mid term. 
Via InvestorPlace
News headline image
Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗
 
Via Benzinga
News headline image
This Growth Stock Is Down 63% in 1 Year. Here's Why You Should Buy the Dip and Hold It for 5 Years ↗
The bear market hasn't been kind, but the future could be a lot better. 
Via The Motley Fool
News headline image
Bragar Eagel & Squire is Investigating Certain Officers and Directors of C3.ai, Ginkgo Bioworks, and Polished on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Ginkgo Bioworks Holdings, Inc. - DNA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Evogene Offers An Excellent Risk/Reward Ratio ↗
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
News headline image
7 Penny Stocks With Massive Growth Potential ↗
If you laugh at red ink, these tempting ideas just might be for you. 
Via InvestorPlace
News headline image
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
News headline image
Buy the Dip: 2 Exceptional Growth Stocks to Grab Before the Next Bull Market ↗
Now's the time to load up on stocks that got dented in the bear market. 
Via The Motley Fool
News headline image
GINKGO BIOWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ginkgo Bioworks Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Cronos Group Reports 2022 Fourth Quarter and Full-Year Results
From Cronos Group Inc.
Via GlobeNewswire
News headline image
To The Moon: Intuitive Machines Blasts 10x in a Week...But Why?
The modern version of the Cold War Space Race has implications for scientific discovery and satellite communications. Intuitive Machines is in the thick of it. 
Via MarketBeat
News headline image
This Biotech Is Already Using AI, but Is the Growth Stock a Buy? ↗
Few biotechs can claim to be using AI in as central of a role as Ginkgo Bioworks. 
Via The Motley Fool
News headline image
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ginkgo Bioworks Holdings Inc. (DNA) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.